Imugene Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Imugene Limited with three other
companies in this sector in Australia:
sales of 3.88 million Australian Dollars [US$2.65 million]
Oncosil Medical Ltd
(3.83 million Australian Dollars [US$2.61 million]
(4.03 million Australian Dollars [US$2.75 million]
of which 176%
was Contract Services).
Imugene Limited reported sales of A$4.54 million (US$3.10 million)
June of 2019.
increase of 134.7%
versus 2018, when the company's sales were A$1.94 million.